Bachhav, N.; Singh, D.K.; Blithe, D.L.; Lee, M.S.; Prasad, B.
Identification of the Biotransformation Pathways of a Potential Oral Male Contraceptive, 11β-Methyl-19-Nortestosterone (11β-MNT) and Its Prodrugs: An In Vitro Study Highlights the Contribution of Polymorphic Intestinal UGT2B17. Pharmaceutics 2024, 16, 1032.
https://doi.org/10.3390/pharmaceutics16081032
AMA Style
Bachhav N, Singh DK, Blithe DL, Lee MS, Prasad B.
Identification of the Biotransformation Pathways of a Potential Oral Male Contraceptive, 11β-Methyl-19-Nortestosterone (11β-MNT) and Its Prodrugs: An In Vitro Study Highlights the Contribution of Polymorphic Intestinal UGT2B17. Pharmaceutics. 2024; 16(8):1032.
https://doi.org/10.3390/pharmaceutics16081032
Chicago/Turabian Style
Bachhav, Namrata, Dilip Kumar Singh, Diana L. Blithe, Min S. Lee, and Bhagwat Prasad.
2024. "Identification of the Biotransformation Pathways of a Potential Oral Male Contraceptive, 11β-Methyl-19-Nortestosterone (11β-MNT) and Its Prodrugs: An In Vitro Study Highlights the Contribution of Polymorphic Intestinal UGT2B17" Pharmaceutics 16, no. 8: 1032.
https://doi.org/10.3390/pharmaceutics16081032
APA Style
Bachhav, N., Singh, D. K., Blithe, D. L., Lee, M. S., & Prasad, B.
(2024). Identification of the Biotransformation Pathways of a Potential Oral Male Contraceptive, 11β-Methyl-19-Nortestosterone (11β-MNT) and Its Prodrugs: An In Vitro Study Highlights the Contribution of Polymorphic Intestinal UGT2B17. Pharmaceutics, 16(8), 1032.
https://doi.org/10.3390/pharmaceutics16081032
